cyc 202 has been researched along with Carotid Arteriopathies, Traumatic in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chang, H; Hou, JM; Li, AY; Li, YF; Liu, Y; Sun, JH; Wang, H; Yu, K; Zhao, JS | 1 |
1 other study(ies) available for cyc 202 and Carotid Arteriopathies, Traumatic
| Article | Year |
|---|---|
Roscovitine Protects From Arterial Injury by Regulating the Expressions of c-Jun and p27 and Inhibiting Vascular Smooth Muscle Cell Proliferation.
Topics: Animals; Aorta, Thoracic; Carotid Artery Injuries; Cell Line, Tumor; Cell Proliferation; Chlorocebus aethiops; COS Cells; Cyclin-Dependent Kinase Inhibitor p27; Cytoprotection; Dose-Response Relationship, Drug; Gene Expression; HeLa Cells; Humans; JNK Mitogen-Activated Protein Kinases; Male; Muscle, Smooth, Vascular; Protein Kinase Inhibitors; Purines; Rats; Rats, Sprague-Dawley; Roscovitine | 2017 |